NCT06682780 2025-09-25
A Phase I/II Study of LM-2417 in Subjects With Advanced Solid Tumours
LaNova Medicines Limited
Phase 1/2 Recruiting
LaNova Medicines Limited
Wigen Biomedicine Technology (Shanghai) Co., Ltd.
Grupo Español de Tratamiento de Tumores de Cabeza y Cuello